APA (7th ed.) Citation

N, P., S, G., DS, D., S-H, F., SC, E., JS, D., . . . SYC, T. (2024). Genomic investigation and clinical correlates of the in vitro β-lactam: NaHCO3 responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial. Antimicrobial agents and chemotherapy, 68(7), e0021824. https://doi.org/10.1128/aac.00218-24

Chicago Style (17th ed.) Citation

N, Petersiel, Giulieri S, Daniel DS, Fan S-H, Ersoy SC, Davis JS, Bayer AS, Howden BP, and Tong SYC. "Genomic Investigation and Clinical Correlates of the in Vitro β-lactam: NaHCO3 Responsiveness Phenotype Among Methicillin-resistant Staphylococcus Aureus Isolates from a Randomized Clinical Trial." Antimicrobial Agents and Chemotherapy 68, no. 7 (2024): e0021824. https://doi.org/10.1128/aac.00218-24.

MLA (9th ed.) Citation

N, Petersiel, et al. "Genomic Investigation and Clinical Correlates of the in Vitro β-lactam: NaHCO3 Responsiveness Phenotype Among Methicillin-resistant Staphylococcus Aureus Isolates from a Randomized Clinical Trial." Antimicrobial Agents and Chemotherapy, vol. 68, no. 7, 2024, p. e0021824, https://doi.org/10.1128/aac.00218-24.